The Premium On HCA Healthcare Keeps Growing. So Does The Case For Universal Health

The hospital giant costs far more than its faster-growing rival, forcing investors to decide if its premium for quality is a fair price or a costly assumption.

In the business of running hospitals, HCA Healthcare (HCA) and Universal Health Services (UHS) are two of the largest players competing for the same healthcare dollars. Yet the stock market values them in starkly different ways. The market currently charges 7.9 times operating profit for HCA, but only 4.8 times for UHS, which is also growing its revenue faster. Over the past year, this valuation gap between the two has widened, making the central question for any investor in the space more pointed: What, exactly, does HCA’s premium still buy?

HCA’s premium buys scale and superior profitability.

The case for HCA begins with its dominant scale and the efficiency that comes with it. With trailing twelve-month revenue of $76.39 billion, HCA is a giant in the industry. This size helps generate a superior operating margin of 15.7%, a figure well ahead of the 11.5% posted by UHS. That profitability is the tangible result of the quality and discipline investors are paying for. A recent analysis explores how HCA’s quiet compounding changes its growth story. Management is actively defending this edge, executing a “broad resiliency plan” to manage costs while pursuing an “AI agenda” to improve care and efficiency. The company is also making strategic moves to secure its future, such as its recent agreement to acquire The College of Health Care Professions to build a pipeline of skilled labor.

The key numbers side by side, today:

OpInc = Operating Income, P/EBIT = Price To Operating Income Ratio

And the same comparison exactly a year ago, so you can see which way the mismatch has been moving:

OpInc = Operating Income

But paying that premium means forgoing faster growth.

The trade-off for HCA’s perceived stability is clear: investors give up the faster revenue growth offered by its cheaper peer. UHS expanded its revenue by 10.4% over the last twelve months, a significantly quicker pace than HCA’s 6.7% growth. More than an abstract number, it represents a business capturing more market share, more quickly. While HCA is a steady giant, UHS offers a different proposition. The market has not rewarded this growth recently, with UHS stock delivering a -12.2% return over the last year, which has contributed to its lower multiple. For investors who prefer exposure to the entire sector rather than a single name, a health care facilities ETF like IHF holds both companies.

The choice turns on HCA’s operational discipline.

Ultimately, the decision hinges on whether HCA’s operational strength can reliably overcome challenges and justify its higher price. The most recent quarter put that discipline to the test. Management noted that results were “a bit short” of internal expectations, impacted by a mild respiratory season and winter storms. The quarter was bolstered by an unexpected net benefit of approximately $200 million from state supplemental payment programs, which offset an estimated $180 million headwind from the volume shortfall. This reliance on non-operational items makes the premium a forward-looking question. An investor is betting HCA’s scale can navigate new pressures, including a “slowdown of conversions to Medicaid” that management recently called “nascent.” Monitoring how that trend develops will be a key test of whether the core business is as durable as its premium implies.

Rather, Compare Them On Your Own Terms?

You can line HCA Healthcare and Universal Health up directly on the HCA Healthcare peer comparison, weigh them on valuation, growth, margins, and returns, and swap in any other Health Care Facilities names you hold.

Whichever Side You Pick, Pick A Process Too

Maybe the premium is earned; maybe the cheaper, faster grower is the smarter hold. Either answer still leaves you with a single stock’s risks: one product cycle, one management team, one industry’s weather.

The Trefis High Quality (HQ) Portfolio spreads that bet across roughly 30 quality businesses selected for consistent cash generation, strong margins, and resilient balance sheets, rebalanced by rules rather than conviction. It has a track record of outpacing a benchmark that combines all major indices – the S&P 500, S&P Mid-cap, and Russell 2000. Decide the pair on the merits; let the portfolio carry the risk.